Supplementation of the population during the COVID-19 pandemic with vitamins and micronutrients - how much evidence is needed?

Swiss Med Wkly. 2021 May 19;151:w20522. doi: 10.4414/smw.2021.20522. eCollection 2021 May 10.
No abstract available

Publication types

  • Review

MeSH terms

  • Ascorbic Acid Deficiency / epidemiology
  • Ascorbic Acid Deficiency / immunology
  • Ascorbic Acid Deficiency / prevention & control
  • Ascorbic Acid Deficiency / therapy
  • COVID-19 / epidemiology*
  • COVID-19 / immunology
  • COVID-19 / prevention & control
  • COVID-19 / therapy
  • Deficiency Diseases / epidemiology
  • Deficiency Diseases / immunology
  • Deficiency Diseases / prevention & control*
  • Deficiency Diseases / therapy
  • Dietary Supplements*
  • Evidence-Based Medicine*
  • Humans
  • Magnesium Deficiency / epidemiology
  • Magnesium Deficiency / immunology
  • Magnesium Deficiency / prevention & control
  • Magnesium Deficiency / therapy
  • Micronutrients / therapeutic use
  • Risk Factors
  • SARS-CoV-2
  • Switzerland
  • Trace Elements / therapeutic use*
  • Treatment Outcome
  • Vitamin B 12 Deficiency / epidemiology
  • Vitamin B 12 Deficiency / immunology
  • Vitamin B 12 Deficiency / prevention & control
  • Vitamin B 12 Deficiency / therapy
  • Vitamin D Deficiency / epidemiology
  • Vitamin D Deficiency / immunology
  • Vitamin D Deficiency / prevention & control
  • Vitamin D Deficiency / therapy
  • Vitamins / therapeutic use*
  • Zinc / deficiency

Substances

  • Micronutrients
  • Trace Elements
  • Vitamins
  • Zinc